Publikationen in Zusammenarbeit mit Forschern von Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (23)

2025

  1. Aspirin, Birthweight, and Large-For-Gestational-Age Neonates: A Secondary Analysis of the ASPRE Trial

    BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 132, Núm. 11, pp. 1606-1614

2024

  1. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study

    Journal of Cystic Fibrosis, Vol. 23, Núm. 5, pp. 815-822

2023

  1. Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia

    Genes, Vol. 14, Núm. 1

  2. The current clinical practice for management of post-infarction ventricular septal rupture: a European survey

    European Heart Journal Open, Vol. 3, Núm. 5

2022

  1. Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation

    Respiratory Medicine, Vol. 192

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  3. Risk of fetal loss after chorionic villus sampling in twin pregnancy derived from propensity score matching analysis

    Ultrasound in Obstetrics and Gynecology, Vol. 59, Núm. 2, pp. 162-168

2021

  1. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial

    American Journal of Obstetrics and Gynecology, Vol. 224, Núm. 1, pp. 86.e1-86.e19

  2. Fetal loss after chorionic villus sampling in twin pregnancy

    Ultrasound in Obstetrics and Gynecology, Vol. 58, Núm. 1, pp. 48-55

  3. Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

    BJS Open

  4. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score

    British Journal of Surgery, Vol. 19, Núm. 4

2018

  1. ASPRE Trial: Incidence of Preterm Preeclampsia in Patients Fulfilling ACOG and NICE Criteria According to Risk by FMF Algorithm

    Obstetrical and Gynecological Survey, Vol. 73, Núm. 11, pp. 623-625

  2. ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm

    Ultrasound in Obstetrics and Gynecology, Vol. 51, Núm. 6, pp. 738-742

  3. Aspirin Versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

    Obstetrical and Gynecological Survey

  4. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit

    American Journal of Obstetrics and Gynecology, Vol. 218, Núm. 6, pp. 612.e1-612.e6

  5. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE

    Ultrasound in Obstetrics and Gynecology, Vol. 52, Núm. 1, pp. 52-59

  6. Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

    Ultrasound in Obstetrics and Gynecology, Vol. 52, Núm. 2, pp. 186-195

2017

  1. ASPRE trial: performance of screening for preterm pre-eclampsia

    Ultrasound in Obstetrics and Gynecology, Vol. 50, Núm. 4, pp. 492-495

  2. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

    Ultrasound in Obstetrics and Gynecology, Vol. 49, Núm. 6, pp. 751-755

  3. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history

    American Journal of Obstetrics and Gynecology, Vol. 217, Núm. 5, pp. 585.e1-585.e5